AstraZeneca Pharmaceuticals LP (quality control (excluding sterility and endotoxin))

The drug is prescribed for the treatment of adult patients with non-small cell lung cancer (either in combination with chemotherapy or after surgery or in unresectable cases), small cell lung cancer (as first-line therapy in combination with chemotherapy), as well as biliary tract cancer (in combination with gemcitabine and cisplatin).

Dosage form: concentrate for infusion solution

ATC: L01FF03